Characterization of Clinical and Genetic Risk Factors Associated with Dyslipidemia after Kidney Transplantation

Table 1

Comparison of clinical characteristics between patients with dyslipidemia and without dyslipidemia.

	With dyslipidemia ( = 44)	Without dyslipidemia ( = 82)
At transplantation
Age (yrs)	49.2 ± 10.3	46.3 ± 12.8	0.205
Gender (male : female)	21 : 23	57 : 25	0.021
BMI (kg/m^2)	22.0 ± 3.5	22.6 ± 4.0	0.421
Dialysis duration (mos)	47.9 ± 54.6	49.0 ± 73.9	0.936
Donor age (yrs)	55.7 ± 12.7	58.4 ± 10.1	0.219
ABO incompatible	16	16	0.162
HCV antibody positive	1	2	0.970
1 yr after transplantation
CMV infection	11	16	0.700
Acute rejection	17	30	0.951
DM	13	22	0.777
Hypertension	32	62	0.773
Hyperuricemia	18	40	0.354
eGFR	54.1 ± 14.1	51.0 ± 14.7	0.306

Chi-square tests were used to test categorical data, whereas Mann-Whitney tests were employed to analyze continuous values between groups.
values less than 0.05 were considered to be statistically significant.
Values are expressed as mean ± SD.
BMI, body mass index; eGFR, estimated glomerular filtration rate; HCV, hepatitis C virus; CMV, cytomegalovirus; DM, diabetes mellitus.